SYMBIOTEC
NSE#126 by turnoverSYMBIOTEC
Key statistics
- Open
- ₹1,158.00
- Day range
- 1,138.20 – 1,196.80
- 52-week range
- —
- From 52w high
- —
- Volume
- 20.16L
- Turnover
- ₹237.3Cr
- Delivery
- 35.9%
- Rel volume
- 1.04×
- RSI (14)
- 59.7
- ATR (14)
- 67.96
- SMA 50
- —
- SMA 200
- —
20-day avg 29.6%
Performance
- 1 day
- +2.84%
- 1 week
- +10.81%
- 1 month
- —
- 3 months
- —
- 6 months
- —
- 1 year
- —
Delivery percentage
- Latest
- 35.9%
- 20-day avg
- 29.6%
- 1-year avg
- 29.7%
- Percentile
- 90th
- Range
- 14.4–46.7%
30 Sept 2026
Against its own sessions
21 sessions
Over the last 20 sessions SYMBIOTEC settled 29.6% of its traded quantity, which is ordinary for an NSE equity.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹7,561 Cr
- P/E (TTM)
- —
- EPS (TTM)
- —
- Shares outstanding
- 6.27Cr
- Listed
- 1 Sept 2026
no positive TTM earnings
Q1 FY27
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growthlatest filed quarter Q1 FY27
- Revenue YoY
- —
- Profit YoY
- —
- Revenue QoQ
- —
- Profit QoQ
- —
- Interest cost YoY
- —
Compound growth
Not enough filed history for a compound growth rate yet.
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE899I01028
- Series
- EQ
- History from
- 1 Sept 2026
- Sessions
- 21
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 30 Sept 2026.